Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
Clinical trial NCT06566079 · RECRUITING
Trial details
- NCT number
- NCT06566079
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-27
- Primary completion
- 2027-08-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.